Indonesia allows Taiwan's COVID-19 vaccine candidate to conduct clinical trial
09/13/2021 12:05 PM
Taiwanese vaccine producer Adimmune Corp. said on Monday that it has gained approval from the Indonesian government to conduct Phase 2 clinical trials for its COVID-19 vaccine candidate, with results expected to be released next year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar up in Taipei trading
04/17/2025 10:38 AM - Business
Taiwan shares open lower
04/17/2025 09:27 AM - Culture
Exhibition on Taiwan's Indigenous culture opens in Prague
04/16/2025 09:55 PM - Politics
Taiwan, Tuvalu sign two deals on labor cooperation
04/16/2025 09:06 PM - Cross-Strait
Taiwan rebuts China's criticism of deregistration rule
04/16/2025 08:55 PM